Structure-Activity Relationships in Toll-like Receptor-2 Agonistic Diacylthioglycerol Lipopeptides

被引:68
|
作者
Wu, Wenyan [1 ]
Li, Rongti [1 ]
Malladi, Subbalakshmi S. [1 ]
Warshakoon, Hemamali J. [1 ]
Kimbrell, Matthew R. [1 ]
Amolins, Michael W. [1 ]
Ukani, Rehman [1 ]
Datta, Apurba [1 ]
David, Sunil A. [1 ]
机构
[1] Univ Kansas, Dept Med Chem, Lawrence, KS 66047 USA
关键词
MACROPHAGE-ACTIVATING LIPOPEPTIDE-2; ESCHERICHIA-COLI LIPOPROTEIN; ADAPTIVE IMMUNE-RESPONSE; BACTERIAL-CELL WALLS; HIV-1 TAT PROTEIN; LIPOTEICHOIC ACID; INNATE IMMUNITY; STAPHYLOCOCCUS-AUREUS; MYCOPLASMA-FERMENTANS; PEPTIDOGLYCAN;
D O I
10.1021/jm901839g
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The N-termini of bacterial lipoproteins are acylated with a (S)-(2,3-bisacyloxypropyl)cysteinyl residue. Lipopeptides derived from lipoproteins activate innate immune responses by engaging Toll-like receptor 2 (TLR2) and are highly immunostimulatory and yet without apparent toxicity in animal models. The lipopeptides may therefore be useful as potential immunotherapeutic agents. Previous structure activity relationships in such lipopeptides have largely been obtained using murine cells, and it is now clear that significant species-specific differences exist between human and murine TLR responses. We have examined in detail the role of the highly conserved Cys residue as well as the geometry and stereochemistry of the Cys-Ser dipeptide unit. (R)-Diacylthioglycerol analogues are maximally active in reporter gene assays using human TLR2. The Cys-Ser dipeptide unit represents the minimal part-structure, but its stereochemistry was found not to be a critical determinant of activity. The thioether bridge between the diacyl and dipeptide units is crucial, and replacement by an oxoether bridge results in a dramatic decrease in activity.
引用
收藏
页码:3198 / 3213
页数:16
相关论文
共 50 条
  • [41] Toll-like receptor-4 is upregulated in plaque debris of patients with acute coronary syndrome more than Toll-like receptor-2
    Satoh, Shinji
    Yada, Ryoko
    Inoue, Hiroko
    Omura, Soichiro
    Ejima, Emiko
    Mori, Takahiro
    Takenaka, Katsuhiko
    Kawamura, Natsumi
    Numaguchi, Kotaro
    Mori, Etsuo
    Asoh, Akemi
    Nakamura, Toshihiro
    Hiyamuta, Koji
    HEART AND VESSELS, 2016, 31 (01) : 1 - 5
  • [42] Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction
    Shishido, T
    Nozaki, N
    Yamaguchi, S
    Shibata, Y
    Nitobe, J
    Miyamoto, T
    Takahashi, H
    Arimoto, T
    Maeda, K
    Yamakawa, M
    Takeuchi, O
    Akira, S
    Takeishi, Y
    Kubota, I
    CIRCULATION, 2003, 108 (23) : 2905 - 2910
  • [43] Toll-Like Receptor-2 Mediates Inflammation and Matrix Degradation in Human Atherosclerosis
    Monaco, Claudia
    Gregan, Scott M.
    Navin, Tina J.
    Foxwell, Brian M. J.
    Davies, Alun H.
    Feldmann, Marc
    CIRCULATION, 2009, 120 (24) : 2462 - 2469
  • [44] Propionibacterium acnes CAMP factor 1 recognized Toll-Like Receptor-2
    Grange, P. A.
    Lheure, C.
    Ollagnier, G.
    Morand, P.
    Desire, N.
    Sayon, S.
    Corvec, S.
    Marcelin, A.
    Dreno, B.
    Dupin, N.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (10) : S257 - S257
  • [45] Toll-like receptor-2 and disturbances of the cardiac rhythm: Life changes in a heartbeat
    Chima, Ranjit S.
    Zingarelli, Basilia
    CRITICAL CARE MEDICINE, 2010, 38 (10) : 2062 - 2063
  • [46] Hypomethylation of the Toll-like receptor-2 gene increases the risk of essential hypertension
    Mao, Shuqi
    Gu, Tianlun
    Zhong, Fade
    Fan, Rui
    Zhu, Fubao
    Ren, Peipei
    Yin, Fengying
    Zhang, Lina
    MOLECULAR MEDICINE REPORTS, 2017, 16 (01) : 964 - 970
  • [47] Toll-like receptor-2 and-4 expressions in pre-eclampsia.
    Xie, F.
    Hu, Y.
    Magee, L. A.
    Money, D. M.
    Thomas, E.
    Speert, D. P.
    Patrick, D.
    Krajden, M.
    Brunham, R. C.
    von Dadelszen, P.
    HYPERTENSION IN PREGNANCY, 2006, 25 : 9 - 9
  • [48] Increased platelet toll-like receptor-2 and 4 expression in atrial fibrillation
    Gurses, K. M.
    Kocyigit, D.
    Yalcin, M. U.
    Canpinar, H.
    Evranos, B.
    Tokgozoglu, L.
    Oto, M. A.
    Guc, D.
    Ozer, N.
    Aytemir, K.
    EUROPEAN HEART JOURNAL, 2015, 36 : 1077 - 1077
  • [49] Toll-like receptor-2 mediates inflammation and matrix degradation in human atherosclerosis
    Monaco, C.
    Gregan, S. M.
    Navin, T. J.
    Foxwell, B. M. J.
    Davies, A. H.
    Feldmann, M.
    EUROPEAN HEART JOURNAL, 2009, 30 : 25 - 25
  • [50] TOLL-LIKE RECEPTOR-2 MEDIATES INFLAMMATION AND MATRIX DEGRADATION IN HUMAN ATHEROSCLEROSIS
    Monaco, C.
    Gregan, S. M.
    Navin, T. J.
    Foxwell, B. M. J.
    Davies, A. H.
    Feldmann, M.
    HEART, 2009, 95 (22)